Vident Investment Advisory, LLC Sarepta Therapeutics, Inc. Transaction History

Vident Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $177,723 - $249,141	-2,694 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $241,650 - $302,150	-3,483 Reduced 56.39%	2,694 $209,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $129,110 - $301,913	-1,787 Reduced 22.44%	6,177 $460,000
Q4 2020 Feb 08, 2021	BUY	$125.56 - $178.74 $54,241 - $77,215	432 Added 5.74%	7,964 $1.36 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $200,086 - $271,263	1,574 Added 26.42%	7,532 $1.06 Million
Q2 2020 Jul 17, 2020	BUY	$93.0 - $171.7 $330,522 - $610,221	3,554 Added 147.84%	5,958 $955,000
Q1 2020 May 12, 2020	BUY	$82.38 - $131.64 $17,052 - $27,249	207 Added 9.42%	2,404 $235,000
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $168,136 - $297,869	2,197 New	2,197 $284,000
Q2 2019 Aug 12, 2019	SELL	$112.21 - $151.95 $220,380 - $298,429	-1,964 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$106.67 - $151.68 $63,255 - $89,946	-593 Reduced 23.19%	1,964 $234,000
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $15,571 - $23,801	-160 Reduced 5.89%	2,557 $279,000
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $313,297 - $438,822	2,717 New	2,717 $439,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.